StonvexLoading…
StonvexStonvexStonvexCore line items from FTRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.72B | $2.70B | $2.84B | $2.84B |
Operating Income | $-872.60M | $-161.90M | $32.00M | $187.10M |
Net Income | $-986.20M | $-328.50M | $-25.20M | $186.20M |
EPS (Diluted) | $-10.81 | $-3.67 | $-0.29 | $2.09 |
Total Assets | $2.72B | $3.58B | $4.33B | $4.29B |
Total Liabilities | $2.15B | $2.22B | $2.62B | $945.30M |
Cash & Equivalents | $174.60M | $118.50M | $108.60M | $112.00M |
Free Cash Flow OCF − CapEx | $88.30M | $237.30M | $128.10M | $28.30M |
Shares Outstanding | 93.10M | 89.70M | 88.80M | 0 |